XAF1 as a modifier of p53 function and cancer susceptibility

Journal: Science Advances

Published: 2020-06-01

DOI: 10.1126/sciadv.aba3231

Affiliations: 29

Authors: 64

Go to article
Institutions Share
St. Jude Children's Research Hospital (St. Jude), United States of America (USA) 0.20
NIH National Cancer Institute (NCI), United States of America (USA) 0.13
University of São Paulo (USP), Brazil 0.09
Center for Applied Bioinformatics (CAB), St. Jude, United States of America (USA) 0.06
Barretos Cancer Hospital, Brazil 0.06
Instituto de Pesquisa Pelé Pequeno Príncipe, Brazil 0.06
A.C. Camargo Cancer Center (CIPE), Brazil 0.05
Federal University of Rio Grande do Sul (UFRGS), Brazil 0.03
Federal University of Paraná (UFPR), Brazil 0.03
UCL, United Kingdom (UK) 0.03
Sant Joan de Déu Research Institute (IRSJD), Spain 0.03
University of Michigan (U-M), United States of America (USA) 0.03
Cordelier Research Center (CRC), France 0.02
William Harvey Research Institute (WHRI), QMUL, United Kingdom (UK) 0.02
Institute of Molecular and Cellular Pharmacology (IPMC), France 0.02
Hospital do Câncer de Cascavel (UOPECCAN), Brazil 0.02
Hospital Universitario Virgen de la Arrixaca, Spain 0.02
Hospital Sírio-Libanês, Brazil 0.02
University of Pennsylvania (Penn), United States of America (USA) 0.02
Institute Gustave-Roussy (IGR), France 0.02
Centre François Baclesse, France 0.02
Hospital Infantil Joana de Gusmão, Brazil 0.02
Federal University of Bahia (UFBA), Brazil 0.02
Hartwell Center for Bioinformatics and Biotechnology, St. Jude, United States of America (USA) 0.02